Peripheral arterial occlusive disease

2 trials 2 recruiting MedDRA PT
2 Registered trials
2 Recruiting
1 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
ATC code not specified 1
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Heparin / LMWH 1 substance
Unknown / small molecule 1 substance
Phase II: 1 Phase I (Other): 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

1 trial
  • Aplagon Oy Commercial
    HEPARIN SODIUM; UNFRACTIONATED HEPARIN, PORCINE, CONJUGATED WITH HUMAN SERUM ALBUMIN
    2025-522390-11-00 1 country 2026 n=42
    Recruiting

Phase I (Other)

1 trial
  • Aplagon Oy Commercial
    IMP not specified
    2023-505287-11-01 1 country 2024 n=10
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Aplagon Oy Commercial 2 Phase I (Other), Phase II 2
New trials by year
2024
1
2026
1
← All indication landscapes